Evidence map›Paper›PMID 33413448›Full record

ArticleJournal of nanobiotechnology2021

Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.

David Da Costa, Chloé Exbrayat-Héritier, Basile Rambaud, Simon Megy, Raphaël Terreux, Bernard Verrier, Charlotte Primard

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 81 citations in OpenAlex.

  1. Targeting multidrug-resistantMaterials today. Bio · 2026
    Article
  2. Modification of Porous Silicon with an Amphiphilic Quaternary Ammonium Hydrocarbon for Nanomedicine Applications.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
  3. Review
  4. Newly designed nanoparticle-drug delivery systems againstInternational journal of clinical and experimental pathology · 2024
    Review
  5. Review
  6. Article
  7. Bioactive Endodontic Hydrogels: From Parameters to Personalized Medicine.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Overview of Antimicrobial Biodegradable Polyester-Based Formulations.International journal of molecular sciences · 2023
    Review
  14. Regulation ofPharmaceutics · 2023
    Review
  15. Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

David Da CostaLaboratoire de Biologie Tissulaire Et Ingénierie Thérapeutique, UMR5305, CNRS/Université, Lyon 1, Lyon, France. david.da-costa@adjuvatis.com.ORCID https://orcid.org/0000-0002-9080-0292
Chloé Exbrayat-HéritierAdjuvatis, 7 passage du Vercors, 69007, Lyon, France.
Basile RambaudAdjuvatis, 7 passage du Vercors, 69007, Lyon, France.
Simon MegyLaboratoire de Biologie Tissulaire Et Ingénierie Thérapeutique, UMR5305, CNRS/Université, Lyon 1, Lyon, France.
Raphaël TerreuxLaboratoire de Biologie Tissulaire Et Ingénierie Thérapeutique, UMR5305, CNRS/Université, Lyon 1, Lyon, France.
Bernard VerrierLaboratoire de Biologie Tissulaire Et Ingénierie Thérapeutique, UMR5305, CNRS/Université, Lyon 1, Lyon, France.
Charlotte PrimardAdjuvatis, 7 passage du Vercors, 69007, Lyon, France.
Université Claude Bernard Lyon 1 · FR

Funding

Association Nationale de la Recherche et de la Technologie 2017/0613
6 · The paper itself

Abstract

backgroundAfter the golden age of antibiotic discovery, bacterial infections still represent a major challenge for public health worldwide. The biofilm mode of growth is mostly responsible for chronic infections that current therapeutics fail to cure and it is well-established that novel strategies must be investigated. Particulate drug delivery systems are considered as a promising strategy to face issues related to antibiotic treatments in a biofilm context. Particularly, poly-lactic acid (PLA) nanoparticles present a great interest due to their ability to migrate into biofilms thanks to their submicronic size. However, questions still remain unresolved about their mode of action in biofilms depending on their surface properties. In the current study, we have investigated the impact of their surface charge, firstly on their behavior within a bacterial biofilm, and secondly on the antibiotic delivery and the treatment efficacy.

resultsRifampicin-loaded PLA nanoparticles were synthetized by nanoprecipitation and characterized. A high and superficial loading of rifampicin, confirmed by an in silico simulation, enabled to deliver effective antibiotic doses with a two-phase release, appropriate for biofilm-associated treatments. These nanoparticles were functionalized with poly-L-lysine, a cationic peptide, by surface coating inducing charge reversal without altering the other physicochemical properties of these particles. Positively charged nanoparticles were able to interact stronger than negative ones with Staphylococcus aureus, under planktonic and biofilm modes of growth, leading to a slowed particle migration in the biofilm thickness and to an improved retention of these cationic particles in biofilms. While rifampicin was totally ineffective in biofilms after washing, the increased retention capacity of poly-L-lysine-coated rifampicin-loaded PLA nanoparticles has been associated with a better antibiotic efficacy than uncoated negatively charged ones.

conclusionsCorrelating the carrier retention capacity in biofilms with the treatment efficacy, positively charged rifampicin-loaded PLA nanoparticles are therefore proposed as an adapted and promising approach to improve antibiotic delivery in S. aureus biofilms.

Indexed as

RifampinAnti-Bacterial AgentsBiofilmsDrug Delivery SystemsDrug LiberationLactic AcidMicrobial Sensitivity TestsNanoparticlesPolyestersStaphylococcal InfectionsStaphylococcus aureusSurface PropertiesAnti-Bacterial AgentsLactic AcidPolyestersRifampinAntibioticBiofilmDeliveryInteractionPLA nanoparticlesSurface charge

Identifiers

PMID33413448
PMCPMC7792288
OpenAlexW3120094667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.